TRPC3 and melanoma: The pharmacological inhibition of TRPC3 by Pyr3, a pyrazol compound, was shown to decrease melanoma cell proliferation and migration, and knockdown of TRPC3 reduced melanoma cell proliferation (Oda et al., 2017).